Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors: Fisher B, Dignam J, Bryant J, DeCillis A, Wickeham L, Wolmark N, Constantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux R, Shibata H, Terz A, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickney HL J Natl Cancer Inst 1996:88:1529-42